LiSENUS -Lymphatic imaging Sentinel Node Super-Res CEUS

  • Research type

    Research Study

  • Full title

    Detection of metastatic axillary sentinel lymph nodes using ultrafast, super-resolution, dual-contrast enhanced ultrasound imaging in patients with breast cancer

  • IRAS ID

    293812

  • Contact name

    Karina Cox

  • Contact email

    karina.cox@nhs.net

  • Sponsor organisation

    Maidstone and Tunbridge Wells NHS Trust

  • Eudract number

    2021-003796-34

  • Duration of Study in the UK

    2 years, 0 months, 0 days

  • Research summary

    Invasive breast cancer affects 46,000 people every year in the UK. Cancerous cells can spread to armpit lymph nodes through tissue fluid channels and patients may need more extensive treatment if cancer deposits (metastases) are found. Currently, the best way to find cancerous lymph nodes is to surgically remove them and look for metastases. Armpit surgery is necessary because there are no radiology tests reliable enough to replace the operation.

    Most armpit surgery involves the removal of sentinel nodes, which are the first lymph nodes to receive tissue fluid from the breast. If clear of cancer, the rest of the armpit lymph nodes are also likely to be cancer free. Sentinel node removal can cause wound infections (1/10) and long-term arm swelling (1/20). As less than 1/3 of patients have metastases in lymph nodes, about 32,500 patients have unnecessary surgery every year.

    The aim of this research is to develop a contrast ultrasound package (made up of software and equipment) that can be used with ultrasound machines in the breast clinic for armpit scanning. The research builds on technology developed at Imperial College and combines it with studies pioneered at Maidstone using tiny gas filled microbubbles (ultrasound contrast) injected into the breast to find sentinel nodes.

    Sixty breast cancer patients will have the contrast ultrasound procedure at either Maidstone or Charing Cross Hospitals with microbubbles injected into a vein and into the breast. The aim of the clinical studies are to ensure the new ultrasound test can find sentinel node metastases as well as being easy to use, safe, comfortable and cost effective for the NHS. The creation of a contrast ultrasound test to replace armpit surgery promises to improve the quality of life for patients and be cheaper than an operation.

  • REC name

    North East - Tyne & Wear South Research Ethics Committee

  • REC reference

    21/NE/0150

  • Date of REC Opinion

    12 Oct 2021

  • REC opinion

    Further Information Favourable Opinion